DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 33 filers reported holding DEXCOM INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $137,184,872 | -19.2% | 44,000,000 | -26.7% | 2.46% | -4.5% |
| Q1 2023 | $169,793,950 | -21.0% | 60,000,000 | -23.1% | 2.58% | -2.1% |
| Q4 2022 | $215,020,765 | +39.3% | 78,000,000 | 0.0% | 2.64% | +42.5% |
| Q3 2022 | $154,382,000 | +7.3% | 78,000,000 | 0.0% | 1.85% | +10.5% |
| Q2 2022 | $143,873,000 | -39.4% | 78,000,000 | +2.3% | 1.68% | -34.2% |
| Q1 2022 | $237,572,000 | -4.6% | 76,210,000 | 0.0% | 2.55% | -3.7% |
| Q4 2021 | $249,037,000 | -1.8% | 76,210,000 | 0.0% | 2.64% | +5.6% |
| Q3 2021 | $253,655,000 | +27.8% | 76,210,000 | 0.0% | 2.50% | +23.2% |
| Q2 2021 | $198,485,000 | +10.4% | 76,210,000 | -6.2% | 2.03% | +14.6% |
| Q1 2021 | $179,769,000 | – | 81,210,000 | – | 1.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |